In terms of procedures utilized to collect tissue, most of the tissue derived from tumor biopsies performed in clinical practice for the biologic characterization of tumors (72%, n = 750), with a similar proportion of samples collected via biopsy across HER2-low (71%, n = 344) and HER2-0 patients (73%, n = 406). This evidence concerns the gene ERBB2 and neoplasm.